NRXP
Price:
$1.32
Market Cap:
$14.19M
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.[Read more]
Industry
Biotechnology
IPO Date
2017-12-04
Stock Exchange
NASDAQ
Ticker
NRXP
According to NRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 193.11%. This represents a change of 250.01% compared to the average of 55.17% of the last 4 quarters.
The mean historical ROE of NRx Pharmaceuticals, Inc. over the last ten years is -76.25%. The current 193.11% ROE has changed -353.25% with respect to the historical average. Over the past ten years (40 quarters), NRXP's ROE was at its highest in in the September 2020 quarter at 182.59%. The ROE was at its lowest in in the March 2021 quarter at -2089.19%.
Average
-76.25%
Median
0.10%
Minimum
-475.57%
Maximum
256.97%
Discovering the peaks and valleys of NRx Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.94%
Maximum Annual ROE = 256.97%
Minimum Annual Increase = -1321.93%
Minimum Annual ROE = -475.57%
Year | ROE | Change |
---|---|---|
2023 | 256.97% | -154.03% |
2022 | -475.57% | 37.97% |
2021 | -344.68% | -1321.93% |
2020 | 28.21% | 1.94% |
2019 | 1.38% | 1.36% |
2018 | 0.10% | -162.87% |
The current ROE of NRx Pharmaceuticals, Inc. (NRXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-187.76%
5-year avg
-106.74%
10-year avg
-76.25%
NRx Pharmaceuticals, Inc.’s ROE is less than BiomX Inc. (0%), greater than Lexaria Bioscience Corp. (-121.74%), greater than Aditxt, Inc. (-82.80%), greater than Nutriband Inc. (-607.01%), less than Quoin Pharmaceuticals, Ltd. (0%), greater than Longeveron Inc. (-76.31%), greater than RenovoRx, Inc. (-112.11%), greater than Virax Biolabs Group Limited (-246.98%), greater than SAB Biotherapeutics, Inc. (-403.38%), greater than Senti Biosciences, Inc. (-115.10%), greater than Cingulate Inc. (-94.04%), greater than Bellicum Pharmaceuticals, Inc. (-91.09%), less than Hillstream BioPharma, Inc. (11.47%), less than null (153.34%), greater than null (-47249.59%),
Company | ROE | Market cap |
---|---|---|
0% | $13.04M | |
-121.74% | $39.79M | |
-82.80% | $4.28M | |
-607.01% | $64.53M | |
0% | $2.86M | |
-76.31% | $31.02M | |
-112.11% | $24.95M | |
-246.98% | $8.86M | |
-403.38% | $32.23M | |
-115.10% | $10.26M | |
-94.04% | $11.66M | |
-91.09% | $778.33K | |
11.47% | $4.17M | |
153.34% | $0 | |
-47249.59% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NRx Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for NRx Pharmaceuticals, Inc. (NRXP)?
What is the highest ROE for NRx Pharmaceuticals, Inc. (NRXP)?
What is the 3-year average ROE for NRx Pharmaceuticals, Inc. (NRXP)?
What is the 5-year average ROE for NRx Pharmaceuticals, Inc. (NRXP)?
How does the current ROE for NRx Pharmaceuticals, Inc. (NRXP) compare to its historical average?